Request a Free Consultation
Specialists will contact you within 24 hours β no obligation.
Specialists will contact you within 24 hours β no obligation.
Over 13 years of specialized experience in stem cell therapy for inherited retinal diseases β serving patients from more than 30 countries with a proven track record.
For over 13 years we have stood at the frontier of regenerative medicine β perfecting stem cell protocols that have transformed the lives of patients who had no other options.
Stargardt Treatment Center was founded with one mission: to harness the healing power of stem cells for patients with degenerative eye conditions. Based in Gurgaon, Haryana β just 20 minutes from Indira Gandhi International Airport β our center serves patients from over 30 countries.
We are proud to be the world's first organization to export Umbilical Cord Mesenchymal Stem Cells (UCMSCs), with our specialty protocols delivered to medical facilities across more than 100 countries.
We specialize in inherited and degenerative retinal diseases where conventional medicine offers limited solutions.
The most common inherited juvenile macular degeneration. Lipofuscin buildup causes progressive central vision loss in children and young adults.
ABCA4 Gene MutationA group of inherited retinal disorders causing gradual loss of central vision. Genetically driven and can affect individuals at any age.
Inherited Retinal DiseasePassed through family lines, causing slow breakdown of light-sensing cells in the macula and a progressive central blind spot.
Familial ConditionCaused by BEST1 gene mutations. Creates a characteristic yellow lesion under the macula. Early therapy can significantly slow progression.
BEST1 Gene MutationFatty yellow deposits accumulate in the macula, damaging photoreceptors and reducing central visual clarity in adults.
RPE DysfunctionInherited conditions causing early-onset vision loss β affecting academics, sports, and independence in children and young adults.
Pediatric & JuvenileA rare, aggressive disorder caused by TIMP3 mutations. Characterized by rapid central vision loss. Early treatment is critical.
TIMP3 MutationPRPH2 mutations cause well-defined central retinal atrophy typically beginning in a patient's 30s or 40s.
Choroidal Atrophy (CACD)Specialists review your diagnosis, medical history, and visual function. Suitability assessed at no charge β in-person or online.
Each patient receives a tailored stem cell protocol based on their condition, genetic profile, and stage of progression.
Using high-precision delivery methods, mesenchymal stem cells are introduced to support the retinal pigment epithelium.
Regular OCT scans and vision assessments post-treatment. Remote follow-up available for international patients.
Medical Disclaimer: Stem cell therapy for retinal diseases is an evolving area of medicine. Individual outcomes vary. Treatment does not guarantee vision restoration. Always consult your local ophthalmologist alongside our team.
Real patient testimonials recorded on video.
Real patient shares experience after stem cell therapy at Stargardt Treatment Center.
Vision improvement results after treatment for macular dystrophy.
International patient journey and results after stem cell therapy for Stargardt disease.
Real experiences from patients who traveled from around the world for treatment.
"After being told there was nothing more that could be done for my Stargardt disease, I found this center. My progression has slowed significantly and I can still read with assistance."
"We traveled a long distance and it was absolutely worth it. The treatment was professional, the team caring, and the results encouraging. My eyesight improved noticeably after treatment."
"Before treatment, my central vision was deteriorating rapidly. After coming here, the progression has slowed significantly. The doctors are honest and genuinely care about patients."
Latest developments in stem cell therapy for retinal diseases.
Stargardt disease affects 1 in 8,000β10,000 people globally. We explain the genetic basis and how stem cell therapy is changing outcomes.
Read More βHow mesenchymal stem cells interact with the retinal pigment epithelium and why they show promise for halting macular dystrophy progression.
Read More βEverything international patients need β medical visas, accommodation, what to bring, and how to continue follow-up care from home.
Read More βAnswers to questions our international patients ask most often.
Our team will answer your questions and review your case β no obligation. First consultation is completely free.